<DOC>
	<DOCNO>NCT02944097</DOCNO>
	<brief_summary>To enhance oral bioavailability antioxidant trans-resveratrol trans-Îµ-viniferin Vineatrol30 grapevine-shoot extract , native powder incorporate micelle . A single dose , single blind , two arm crossover trial conduct . Plasma urine sample collect interval 24 h oral intake native micellar Vineatrol30 ( 500 mg ) , resveratrol content quantify compare formulation . Tolerability dose also control safety parameter plasma .</brief_summary>
	<brief_title>Bioavailability Resveratrol From Vineatrol30 Extract Incorporated Into Micelles</brief_title>
	<detailed_description />
	<mesh_term>Resveratrol</mesh_term>
	<criteria>Healthy Volunteers blood chemistry value within normal range Age : 1835 year BMI : 1925 kg/m2 Pregnancy lactation Alcohol and/or drug abuse Use dietary supplement medication , except contraceptive Any known malignant , metabolic endocrine diseases Previous cardiac infarction Dementia Participation clinical trial within past 6 week prior recruitment Smoking Physical activity 5 h/wk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Bioavailability</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>trans-resveratrol</keyword>
	<keyword>trans-epsilon-viniferin</keyword>
	<keyword>Vineatrol 30</keyword>
</DOC>